Nanjing Chia-tai Tianqing Pharmaceutical
Clinical trials sponsored by Nanjing Chia-tai Tianqing Pharmaceutical, explained in plain language.
-
New pill aims to tame rare, debilitating blood disease
Disease control OngoingThis study is testing an experimental capsule called NTQ5082 for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease. The main goal is to see if the pill can safely and effectively raise patients' hemoglobin levels, reduce the need for blood tr…
Phase: PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Apr 02, 2026 04:27 UTC
-
First human test begins for new drug candidate
Knowledge-focused ENROLLING_BY_INVITATIONThis is a very early study to see if a new injection called NTB003 is safe for people and to learn how the body handles it. It will involve 40 healthy volunteers who will receive different doses. The main goal is to check for side effects and measure the drug's levels in the bloo…
Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC